What sector does Capstone Therapeutics Corp (CAPS) operate in?
Capstone Therapeutics Corp belongs to the Healthcare sector and operates in the Building Materials industry.
What is Capstone Therapeutics Corp (CAPS) current stock price?
As of the latest data, Capstone Therapeutics Corp stock price is $0.55, with a previous close of $0.55. Capstone Therapeutics Corp lost -$0.01 in the last trading session, representing a -1.27% loss.
What is Capstone Therapeutics Corp (CAPS) current market capitalization?
Capstone Therapeutics Corp market cap is approximately 4.54 million.
What is Capstone Therapeutics Corp (CAPS) Earnings Per Share (EPS)?
The trailing EPS is -$8.66.
What is Capstone Therapeutics Corp (CAPS) EBITDA?
Capstone Therapeutics Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.30 million.
Does Capstone Therapeutics Corp (CAPS) pay dividends?
No. Capstone Therapeutics Corp does not pay a dividend.
How did Capstone Therapeutics Corp (CAPS) perform in its most recent earnings report?
In the last report (September 30, 2025), Capstone Therapeutics Corp posted an EPS surprise of -391.67% and a revenue surprise of -12.32%.
When is Capstone Therapeutics Corp (CAPS) next earnings report?
Capstone Therapeutics Corp is expected to release its next earnings report on March 31, 2026.
What is Capstone Therapeutics Corp (CAPS) beta (volatility) score?
Capstone Therapeutics Corp has a beta of -1.208, indicating lower volatility than the overall market.